State News

Displaying results 1-10 (of 65)
 |<  < 1 2 3 4 5 6 7  >  >| 

Step Therapy Legislative Update: Texas Governor Signs Step Therapy Bill into Law

The CSRO is pleased to announce that Texas Governor Greg Abbott has officially signed step therapy bill SB 680 into law.

READ MORE

ARA: CSRO Vice President Presents on PBMs and the Rebate System

The CSRO is pleased to report that CSRO Vice President Madeleine Feldman, MD, FACR, presented at the Arkansas Rheumatology Association, giving attendees an inside look at rising drug prices and the hidden rebate system controlled by pharmacy benefit managers (PBMs).

READ MORE

Biosimilars Bill headed to Nebraska Governor

Legislation that provides the substitution and regulation of biosimilars, LB481, was approved by Nebraska’s Unicameral Legislature on a vote of 47 – 0. The bill now goes to Governor Pete Ricketts for his expected signature.

READ MORE

Step Therapy Legislative Update: Texas Bill is Headed to Governor’s Desk

The CSRO is happy to announce that SB 680, step therapy bill introduced in the Texas Senate on January 31, has passed both the Senate and the House and is now headed to Governor Greg Abbott’s desk.

READ MORE

Step Therapy Legislative Update: Iowa Governor Signs Step Therapy Bill into Law

The CSRO is very happy to announce that Iowa Governor Terry Branstad has officially signed HF 233, step therapy bill introduced in the Iowa House by Representative Joel Fry (R, 27th) on January 23, into law.

READ MORE

Biosimilars Bills Moved in South Carolina and Nebraska

HB3438 was signed by South Carolina Governor Henry McMaster. In Nebraska, LB481, a bill for biosimilars access and regulation, was approved on first round debate.

READ MORE

State Advocacy Spotlight: Step Therapy Legislation Continues to Progress in Florida

Like other states across the country, efforts to address step therapy in Florida are underway and making great progress as key legislation continues to move forward.

READ MORE

Biosimilars Bill Signed in Kansas

On April 13, HB 2055 was signed by Governor Sam Brownback. It included critical patient safety rules that involved a communication within 5 business days from pharmacists to physicians about any biosimilar substitutions.

READ MORE

Step Therapy Legislative Update: Iowa Bill Makes Its Way to Governor’s Desk

The CSRO is pleased to announce that HF 233, step therapy bill introduced in the Iowa House by Representative Joel Fry (R, 27th) on January 23, has passed both the House and the Senate and is now headed to Governor Terry Branstad’s desk.

READ MORE

CRA: How Will Biosimilars Change Rheumatology, Rising Drug Prices: Exposing the Hidden Rebate System

The CSRO was delighted to join the California Rheumatology Alliance in an informal presentation on the effect of biosimilars on rheumatology, and an inside look at rising drug prices and the hidden rebate system controlled by pharmacy benefit managers (PBMs). The panel that presented included Dr. Greg Schmizzi on biosimilars, with Dr. Madelaine Feldman, Pharmacist Keith Bradbury, and Attorney David Balto on PBMs.

READ MORE

Displaying results 1-10 (of 65)
 |<  < 1 2 3 4 5 6 7  >  >|